Streetbeat News

Stock Prices

PAYO

Payoneer Global has updated its FY24 guidance, projecting revenue between $920M and $930M, up from the prior estimate of $895M-$905M. Transaction costs are expected to be around 16.5% of revenue, down from the previous 17.5%. Adjusted EBITDA is forecasted to be between $225M and $235M, an increase from the prior $200M-$210M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:34 am

EYPT

EyePoint Pharmaceuticals has reported cash and investments totaling $280.2 million, which is expected to provide a cash runway into 2026.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:34 am

GFF

Griffon (NYSE:GFF) reported Q3 2024 adjusted EPS of $1.24, missing the analyst estimate of $1.31. Sales were $647.8 million, also below the $688.94 million estimate and down 5.21% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:33 am

EHTH

eHealth has projected its FY24 revenue to be between $470 million and $495 million, surpassing the estimated $466.574 million.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:33 am

EYPT

EyePoint Pharmaceuticals reported Q2 2024 GAAP EPS of $(0.58), missing the $(0.53) estimate. Sales were $9.477M, also missing the $9.593M estimate.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:33 am

EHTH

eHealth (NASDAQ:EHTH) reported Q2 2024 GAAP EPS of $(1.33), missing the $(1.14) estimate by 16.67%. However, sales of $65.856M beat the $55.024M estimate by 19.69%, despite a 1.37% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:32 am

APLT

Applied Therapeutics announced that its cash and cash equivalents of $122.2 million are expected to fund the business into 2026.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:32 am

NYAX

Nayax (NASDAQ: NYAX) reported Q2 2024 GAAP EPS of $(0.08), missing the $(0.01) estimate by 730%. However, sales of $78.087M beat the $77.457M estimate by 0.81%, marking a 39.05% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:32 am

KRNT

Kornit Digital (NASDAQ:KRNT) reported Q2 2024 adjusted EPS of $0.02, beating the $(0.01) estimate, but sales of $48.621M missed the $49.322M estimate. EPS improved significantly from $(0.15) last year, while sales decreased by 13.48% from $56.199M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:32 am

APLT

Applied Therapeutics reported a Q2 2024 GAAP EPS of $(0.13), beating the estimate of $(0.15). Sales were $144.000K, which may not be comparable to the $2.500M estimate.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:31 am